Treatment of FIGO stage Ib cervical carcinoma with nodal involvement

F. Pedulla, M. G. Centurioni, G. Foglia, I. Ferrari, M. Orsatti, V. Vitale, N. Ragni

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

One hundred and eighty one patients with stage Ib cervical cancer underwent hysterectomy with pelvic lymphadenectomy. The overall incidence of lymph node metastases was 20%. Twenty seven (71%) patients with nodal involvement were treated by external radiotherapy (TCT) and 11 (29%) by both chemotherapy and radiotherapy (Lin. Acc.). The overall survival at 5 years was 80%; it was 43% for patients with positive nodes and 89% for patients without metastatic nodal disease. The 3 year survival of patients with positive nodes who underwent radiation therapy by TCT was 58%, while it was 72% for those treated by chemotherapy plus radiotherapy. We observed a recurrence in 23% of the cases, 52% in patients with positive nodes and 15% in those with negative nodes. The association chemo-radiotherapy in patients with metastatic lymph nodes seems to improve the survival and reduce the recurrence rate.

Original languageEnglish
Pages (from-to)59-64
Number of pages6
JournalEuropean Journal of Gynaecological Oncology
Volume15
Issue number1
Publication statusPublished - 1994

Fingerprint

Carcinoma
Radiotherapy
Therapeutics
Survival
Lymph Nodes
Recurrence
Drug Therapy
Lymph Node Excision
Hysterectomy
Uterine Cervical Neoplasms
Neoplasm Metastasis
Incidence

ASJC Scopus subject areas

  • Obstetrics and Gynaecology
  • Oncology

Cite this

Pedulla, F., Centurioni, M. G., Foglia, G., Ferrari, I., Orsatti, M., Vitale, V., & Ragni, N. (1994). Treatment of FIGO stage Ib cervical carcinoma with nodal involvement. European Journal of Gynaecological Oncology, 15(1), 59-64.

Treatment of FIGO stage Ib cervical carcinoma with nodal involvement. / Pedulla, F.; Centurioni, M. G.; Foglia, G.; Ferrari, I.; Orsatti, M.; Vitale, V.; Ragni, N.

In: European Journal of Gynaecological Oncology, Vol. 15, No. 1, 1994, p. 59-64.

Research output: Contribution to journalArticle

Pedulla, F, Centurioni, MG, Foglia, G, Ferrari, I, Orsatti, M, Vitale, V & Ragni, N 1994, 'Treatment of FIGO stage Ib cervical carcinoma with nodal involvement', European Journal of Gynaecological Oncology, vol. 15, no. 1, pp. 59-64.
Pedulla F, Centurioni MG, Foglia G, Ferrari I, Orsatti M, Vitale V et al. Treatment of FIGO stage Ib cervical carcinoma with nodal involvement. European Journal of Gynaecological Oncology. 1994;15(1):59-64.
Pedulla, F. ; Centurioni, M. G. ; Foglia, G. ; Ferrari, I. ; Orsatti, M. ; Vitale, V. ; Ragni, N. / Treatment of FIGO stage Ib cervical carcinoma with nodal involvement. In: European Journal of Gynaecological Oncology. 1994 ; Vol. 15, No. 1. pp. 59-64.
@article{2f3bfe32968e41d7b68ea3692c6a16b4,
title = "Treatment of FIGO stage Ib cervical carcinoma with nodal involvement",
abstract = "One hundred and eighty one patients with stage Ib cervical cancer underwent hysterectomy with pelvic lymphadenectomy. The overall incidence of lymph node metastases was 20{\%}. Twenty seven (71{\%}) patients with nodal involvement were treated by external radiotherapy (TCT) and 11 (29{\%}) by both chemotherapy and radiotherapy (Lin. Acc.). The overall survival at 5 years was 80{\%}; it was 43{\%} for patients with positive nodes and 89{\%} for patients without metastatic nodal disease. The 3 year survival of patients with positive nodes who underwent radiation therapy by TCT was 58{\%}, while it was 72{\%} for those treated by chemotherapy plus radiotherapy. We observed a recurrence in 23{\%} of the cases, 52{\%} in patients with positive nodes and 15{\%} in those with negative nodes. The association chemo-radiotherapy in patients with metastatic lymph nodes seems to improve the survival and reduce the recurrence rate.",
author = "F. Pedulla and Centurioni, {M. G.} and G. Foglia and I. Ferrari and M. Orsatti and V. Vitale and N. Ragni",
year = "1994",
language = "English",
volume = "15",
pages = "59--64",
journal = "European Journal of Gynaecological Oncology",
issn = "0392-2936",
publisher = "S.O.G. CANADA Inc.",
number = "1",

}

TY - JOUR

T1 - Treatment of FIGO stage Ib cervical carcinoma with nodal involvement

AU - Pedulla, F.

AU - Centurioni, M. G.

AU - Foglia, G.

AU - Ferrari, I.

AU - Orsatti, M.

AU - Vitale, V.

AU - Ragni, N.

PY - 1994

Y1 - 1994

N2 - One hundred and eighty one patients with stage Ib cervical cancer underwent hysterectomy with pelvic lymphadenectomy. The overall incidence of lymph node metastases was 20%. Twenty seven (71%) patients with nodal involvement were treated by external radiotherapy (TCT) and 11 (29%) by both chemotherapy and radiotherapy (Lin. Acc.). The overall survival at 5 years was 80%; it was 43% for patients with positive nodes and 89% for patients without metastatic nodal disease. The 3 year survival of patients with positive nodes who underwent radiation therapy by TCT was 58%, while it was 72% for those treated by chemotherapy plus radiotherapy. We observed a recurrence in 23% of the cases, 52% in patients with positive nodes and 15% in those with negative nodes. The association chemo-radiotherapy in patients with metastatic lymph nodes seems to improve the survival and reduce the recurrence rate.

AB - One hundred and eighty one patients with stage Ib cervical cancer underwent hysterectomy with pelvic lymphadenectomy. The overall incidence of lymph node metastases was 20%. Twenty seven (71%) patients with nodal involvement were treated by external radiotherapy (TCT) and 11 (29%) by both chemotherapy and radiotherapy (Lin. Acc.). The overall survival at 5 years was 80%; it was 43% for patients with positive nodes and 89% for patients without metastatic nodal disease. The 3 year survival of patients with positive nodes who underwent radiation therapy by TCT was 58%, while it was 72% for those treated by chemotherapy plus radiotherapy. We observed a recurrence in 23% of the cases, 52% in patients with positive nodes and 15% in those with negative nodes. The association chemo-radiotherapy in patients with metastatic lymph nodes seems to improve the survival and reduce the recurrence rate.

UR - http://www.scopus.com/inward/record.url?scp=0028208017&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028208017&partnerID=8YFLogxK

M3 - Article

C2 - 8206073

AN - SCOPUS:0028208017

VL - 15

SP - 59

EP - 64

JO - European Journal of Gynaecological Oncology

JF - European Journal of Gynaecological Oncology

SN - 0392-2936

IS - 1

ER -